February 4, 2025
February 4, 2025, marks World Cancer Day!
This annual international awareness day, led by the Union for International Cancer Control (UICC) since 2000, helps to unite and support the cancer community and mobilize individuals, organizations and governments to ensure that cancer prevention, reduction of the global cancer burden, and equitable access to cancer treatment and care, remain a top priority for global health.
To maximize impact, Word Cancer Day campaigns run in three-year cycles, and the theme for 2025-2027 is United by Unique, which places people at the center of cancer care and aims to explore people-centered approaches to improve health outcomes.
In this first year of the United by Unique campaign, all individuals impacted by cancer (those living with cancer, their families and caregivers), as well as medical professionals and advocates, are being asked to share their personal cancer stories to showcase the diverse challenges faced by the cancer community and gather a broad range of perspectives on how people-centered care could respond to these unique experiences.
To find out more about the campaign and how you can get involved visit the World Cancer Day website.
Acute, episodic and chronic pain are common symptoms of cancer and may persist even after the end of treatment. Cancer-related pain has a major impact on quality of life (QoL) for both cancer patients and cancer survivors. Regular assessments of the prevalence of pain are therefore essential to help improve pain management.
Our medical communication agency recently assisted Charles Ragusa, Bruno Pereira, and David Balayssac, based at the Clermont-Ferrand university hospital in France, with the writing of a scientific article describing the results of a French nationwide web-based survey conducted in 2023 to assess the prevalence, characteristics, and impact on QoL of pain in individuals who were undergoing anticancer treatment and in those who had completed their treatment.
The findings showed that, despite advances in pain management, cancer-related pain remained a common symptom both during and after anticancer therapy (affecting 49.2% of patients and 40.1% of survivors in France) and had negative impact on QoL and global health status. The introduction of more tailored and patient-centered approaches, including patient education and more support for self-management, were discussed as potential strategies for improving pain control.
Find out more by reading the full article here: https://pubmed.ncbi.nlm.nih.gov/39625069/
Pain management and cancer are part of the fields of expertise of our medical writing team not only in the context of marketing authorization applications (MAA), but also for scientific publications.
For example, medical writers from our team have assisted clients in the drafting of manuscripts dealing with bladder cancer, kidney cancer, skin cancer, and the management of xerosis, one of the most frequent side effects of cancer therapy.